- Pathophysiology and complications of skin failure and other severe dermatoses
- Pharmacotherapy
- Photobiology
Clinical pharmacology of systemic drugs
-
Clinical pharmacology of:
-
injectables used in dermatology practice, including, but not limited to:
- corticosteroids
- local anaesthetics
-
topical drugs, covering absorption, clinical use, distribution, mechanism of action, and structure, including adverse effects, clinical indications, contraindications, and drug interactions, for specific topical therapies, including, but not limited to:
- anti-infective agents
- anti-inflammatory agent
- cytotoxic drugs
- emollients
- immunomodulatory agents
- keratolytics
- photosensitisers
- retinoids
-
Pharmacology, covering the absorption, clinical use, distribution, mechanism of action, metabolism and excretion, and structure, including adverse effects, clinical indications, contraindications, and drug interactions, for drugs used in dermatology, including, but not limited to:
- antiandrogens
- anti-infective agents
- anti-inflammatory and immunomodulatory / suppressive
- biologics
- new and emerging drugs relevant to dermatology
- psoralens
- retinoids
- targeted therapies
PCH
- Altered pharmacodynamics and pharmacokinetics of medications in children
- Eligibility for childhood vaccinations
- Potential effects of medications on normal growth and development
- Community Schedule of fully and partially funded pharmaceuticals Named Patient Pharmaceutical Assessment (NPPA) process
- Patient decision making through provision of information regarding treatment choices
- Pharmac initial and renewal funding criteria
- Special authority
- Unfunded medication availability in Aotearoa New Zealand, and current legislation regarding access
- Issues around use of multiple immunosuppressive agents and off-label medications
- Presentation and discussion of complex patients and treatment regimens at multidisciplinary meetings
- Principles of treatment decisions for disorders with limited evidence-base
- Appropriate laboratory, physical, and radiological monitoring of treatments prescribed or used
- Management of acutely unwell dermatology patients:
- investigation and management of causes and complications of skin failure and other severe dermatoses
- Recognition and management of acute adverse drug reactions and anaphylaxis
- Relevant disease assessment tools
- Side effects of phototherapy, surgery, and other treatments
- Value of shared decision making
PCH
- Safe paediatric drug dose calculation
- Clear guidance regarding follow-up requirements for patients and primary care providers
- Management of acutely unwell dermatology patients:
- recognition and management of acute adverse drug reactions and anaphylaxis
- Prescribing per regulatory guidelines
